Search - tctmd.com

Displaying 241 - 260 of 425

Sort: Relevancy | Date

COVID-19: TCTMD’s Dispatch for October Week 4

News Daily News

COVID-19: TCTMD’s Dispatch for October Week 4

October 25, 2021

Higher CV Mortality Among More Socially Vulnerable US Adults

News Daily News

Higher CV Mortality Among More Socially Vulnerable US Adults

Yael L. Maxwell

October 20, 2021

FDA Issues New Guidance on Sodium Targets for Food Industry

News Daily News

FDA Issues New Guidance on Sodium Targets for Food Industry

October 14, 2021

Antithrombotic therapy does not provide a benefit for clinically stable but symptomatic outpatients with COVID-19, published results of the ACTIV-4b trial affirm. Neither aspirin nor apixaban (Eliquis; Bristol Myers Squibb) at prophylactic or therapeutic doses reduced what were already very low rates of major adverse cardiopulmonary outcomes versus placebo, and both modestly increased bleeding, researchers led by Jean Connors, MD (Brigham and Women’s Hospital, Boston, MA), report in a paper published online

News Daily News

ACTIV-4b: No Antithrombotic Therapy Needed for COVID-19 Outpatients

October 13, 2021

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

News Daily News

Post-ACS Patients With Low LDL Levels Remain at Risk: IMPROVE-IT

Michael O'Riordan

October 04, 2021

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

News Daily News

Class I Recall for Cordis’ Super Torque Catheters with Radiopaque Markers

Michael O'Riordan

September 23, 2021

Cumulative Burden of LDL Cholesterol Increases CHD Risk

News Daily News

Cumulative Burden of LDL Cholesterol Increases CHD Risk

Michael O'Riordan

September 23, 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

News Conference News ESC 2021

Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention

Michael O'Riordan

August 31, 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

TOMAHAWK: Swift Angiography No Benefit in OHCA Without STEMI

News Conference News ESC 2021

TOMAHAWK: Swift Angiography No Benefit in OHCA Without STEMI

August 29, 2021

Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’

News Conference News ESC 2021

Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’

August 28, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 4

August 22, 2021

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

News Daily News

Uptick in ‘Implausible’ Cancers Reported After ARB Recalls

August 20, 2021

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

News Daily News

Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data

August 16, 2021

Stroke Better Tackled by Mobile Interventional Teams Than by ‘Drip-and-Ship’

News Daily News

Stroke Better Tackled by Mobile Interventional Teams Than by ‘Drip-and-Ship’

Yael L. Maxwell

August 05, 2021

Catheter Ablation ‘Good Value’ in CABANA Economic Analysis

News Conference News HRS 2021

Catheter Ablation ‘Good Value’ in CABANA Economic Analysis

Michael O'Riordan

August 04, 2021

COVID-19: TCTMD’s Daily Dispatch for August Week 1

News Daily News

COVID-19: TCTMD’s Daily Dispatch for August Week 1

August 01, 2021

COVID-19: TCTMD’s Daily Dispatch for July Week 4

News Daily News

COVID-19: TCTMD’s Daily Dispatch for July Week 4

July 26, 2021

COVID-19: TCTMD’s Daily Dispatch for July Week 3

News Daily News

COVID-19: TCTMD’s Daily Dispatch for July Week 3

July 19, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.